Aggregation-induced emission photosensitizer microneedles for enhanced melanoma photodynamic therapy

• Published in: Biomaterials science 2024-02, Vol.12 (5), p.1263-1273
• Main Authors: Liang, Ling, Peng, Tuokai, Geng, Xin Yao, Zhu, Wenping, Liu, Chaoyong, Peng, Hui-Qing, Chen, Bo Zhi, Guo, Xin Dong
• Format: Article
• Language: English
• Subjects: Animals; Cell Line, Tumor; Conical bodies; Dissolution; Light irradiation; Melanoma; Melanoma - drug therapy; Mice; Nanoparticles - chemistry; Needles; Photochemotherapy - methods; Photodegradation; Photodynamic therapy; Photosensitizing Agents - chemistry; Reactive Oxygen Species - metabolism; Side effects; Skin cancer; Skin Neoplasms - drug therapy; Tumors; White light
• ISSN: 2047-4830; 2047-4849
• DOI: 10.1039/d3bm01819a

The incidence and mortality rates of skin melanoma have been increasing annually. Photodynamic therapy (PDT) enables effective destruction of tumor cells while minimizing harm to normal cells. However, traditional photosensitizers (PSs) suffer from photobleaching, photodegradation and the aggregation-caused quenching (ACQ) effect, and it is challenging for light to reach the deep layers of the skin to maximize the efficacy of PSs. Herein, we developed dissolving microneedles (MNs) loaded with PSs of TPE-EPy@CB[7] through supramolecular assembly. The PSs effectively enhanced the type-I reactive oxygen species (ROS) generation capacity, with a concentration of 2 μM possessing nearly half of the tumor cell-killing ability under 10 min white light irradiation. The MNs were successfully pierced into the targeted site for precise drug delivery. Additionally, the conical structure of the MNs, as well as the lens-like structure after dissolution, facilitated the transmission of light in the subcutaneous tissue, achieving significant inhibition of tumor growth with a tumor suppression rate of 97.8% and no systemic toxicity or side effects in melanoma mice. The results demonstrated the potent melanoma inhibition and biosafety of this treatment approach, exhibiting a new and promising strategy to conquer malignant melanoma. The AIE photosensitiser TPE-EPy@CB[7] was prepared by supramolecular self-assembly, which effectively enhanced the type-I ROS generation capacity. MNs facilitated precise drug delivery and enhanced light penetration into deeper layers of the tumor.